Literature DB >> 61431

Immunoblastic sarcoma arising in child with immunoblastic lymphadenopathy.

C B Howarth, C C Bird.   

Abstract

Entities:  

Mesh:

Year:  1976        PMID: 61431     DOI: 10.1016/s0140-6736(76)90049-0

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  7 in total

1.  Clonal T-cell populations in angioimmunoblastic lymphadenopathy and angioimmunoblastic lymphadenopathy-like lymphoma.

Authors:  L M Weiss; J G Strickler; R F Dorfman; S J Horning; R A Warnke; J Sklar
Journal:  Am J Pathol       Date:  1986-03       Impact factor: 4.307

2.  Immunoblastic sarcoma arising in angioimmunoblastic lymphadenopathy.

Authors:  N Olgun; V Tavli; S Kavukcu; N Cevik; S Gogus; N Cevik
Journal:  Indian J Pediatr       Date:  1993 Sep-Oct       Impact factor: 1.967

3.  Angioimmunoblastic lymphadenopathy. Fine structure of the lymph nodes by correction of light and electron microscopical findings.

Authors:  U Schnaidt; J Thiele; A Georgii
Journal:  Virchows Arch A Pathol Anat Histol       Date:  1980

4.  Rapidly fatal respiratory failure and angioimmunoblastic lymphadenopathy: possible contributions of immunoblastic leukaemia, chemotherapy, and multiple antibodies directed against mature blood cells.

Authors:  P M Trenchard; J A Whittaker; J Gough; H Parry
Journal:  J Clin Pathol       Date:  1981-05       Impact factor: 3.411

5.  Immunological studies in angioimmunoblastic lymphadenopathy.

Authors:  A Skibin; T Yeremiyahu; A Keynan; M R Quastel
Journal:  Clin Exp Immunol       Date:  1980-02       Impact factor: 4.330

6.  Malignant progression of angioimmunoblastic lymphadenopathy.

Authors:  M Bamberg; K Donhuijsen; P G Höher; H Holfeld; D K Hossfeld
Journal:  J Cancer Res Clin Oncol       Date:  1979-04-12       Impact factor: 4.553

7.  Immunopathology of angioimmunoblastic lymphadenopathy.

Authors:  D B Jones; M Castleden; J L Smith; B L Mepham; D H Wright
Journal:  Br J Cancer       Date:  1978-06       Impact factor: 7.640

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.